We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLF icon
651
Cleveland-Cliffs
CLF
$6.57B
$866K 0.03%
42,302
+2,982
+8% +$61.7K
BPL
652
DELISTED
Buckeye Partners, L.P.
BPL
$866K 0.03%
11,524
-1,546
-12% -$112K
CALD
653
DELISTED
Callidus Software, Inc.
CALD
$864K 0.03%
+69,031
New +$907K
LBTYA icon
654
Liberty Global Class A
LBTYA
$3.62B
$862K 0.03%
+25,113
New +$883K
PKW icon
655
Invesco BuyBack Achievers ETF
PKW
$1.72B
$862K 0.03%
19,807
+6,050
+44% +$257K
FMO
656
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$858K 0.03%
6,605
-21
-0.3% -$2.68K
CKSW
657
DELISTED
CLICKSOFTWARE TECH LTD
CKSW
$856K 0.03%
84,569
-838
-1% -$7.89K
XBI icon
658
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$853K 0.03%
17,967
+13,047
+265% +$668K
GHL
659
DELISTED
Greenhill & Co., Inc.
GHL
$849K 0.03%
16,324
ACTG icon
660
Acacia Research
ACTG
$428M
$846K 0.03%
55,335
+45,085
+440% +$656K
CLX icon
661
Clorox
CLX
$11.6B
$846K 0.03%
9,615
-4,756
-33% -$418K
DRI icon
662
Darden Restaurants
DRI
$23.3B
$845K 0.03%
18,632
+1,591
+9% +$71.1K
GURU icon
663
Global X Guru Index ETF
GURU
$61.3M
$843K 0.03%
+34,135
New +$851K
STPZ icon
664
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$506M
$840K 0.03%
15,861
+2,753
+21% +$146K
IMOS
665
ChipMOS TECHNOLOGIES
IMOS
$1.65B
$838K 0.03%
34,486
TRMB icon
666
Trimble
TRMB
$13.2B
$837K 0.03%
21,539
-205
-0.9% -$7.38K
OVTI
667
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$837K 0.03%
47,300
-34,250
-42% -$556K
BCV
668
Bancroft Fund
BCV
$133M
$835K 0.03%
42,718
+1,475
+4% +$28.5K
EEFT icon
669
Euronet Worldwide
EEFT
$2.72B
$832K 0.02%
20,008
LBTYK icon
670
Liberty Global Class C
LBTYK
$3.53B
$832K 0.02%
+25,276
New +$845K
MGA icon
671
Magna International
MGA
$18.7B
$831K 0.02%
+17,254
New +$766K
PJP icon
672
Invesco Pharmaceuticals ETF
PJP
$442M
$831K 0.02%
14,669
+10,013
+215% +$569K
JBLU icon
673
JetBlue
JBLU
$2.28B
$830K 0.02%
95,525
+72,800
+320% +$638K
XHB icon
674
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
$827K 0.02%
25,384
-18,592
-42% -$604K
LTXB
675
DELISTED
LegacyTexas Financial Group Inc
LTXB
$825K 0.02%
28,625
+255
+0.9% +$6.6K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.